101 – 110 of 117
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Artificial neural networks predict survival from pancreatic cancer after radical surgery.
(
- Contribution to journal › Article
-
Mark
Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity.
(
- Contribution to journal › Article
- 2012
-
Mark
Celecoxib synergizes human pancreatic ductal adenocarcinoma cells to sorafenib-induced growth inhibition.
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer: Translational research aspects and clinical implications.
(
- Contribution to journal › Article
-
Mark
Prognostic models for outcome following liver resection for colorectal cancer metastases: A systematic review.
(
- Contribution to journal › Scientific review
-
Mark
Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors.
(
- Contribution to journal › Article
-
Mark
Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?
(
- Contribution to journal › Article
-
Mark
Repeated Liver Resection for Colorectal Liver Metastases: A Comparison with Primary Liver Resections concerning Perioperative and Long-Term Outcome.
(
- Contribution to journal › Article
-
Mark
Solitary liver lesions of indeterminate malignancy - outcome following surgical resection.
(
- Contribution to journal › Article
-
Mark
Polysaccharide-K (PSK) increases p21(WAF/Cip1) and promotes apoptosis in pancreatic cancer cells.
(
- Contribution to journal › Article